U.S. Accuses CVS of Defrauding Medicare over Prescriptions

E6011 & Tocilizumab Monotherapy Studies Show Promising Results for RA Patients

Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More

Brodalumab Approved for Plaque Psoriasis, Plus Baricitinib Effiicacy Studied for RA

Biosimilar Drugs Raise Questions around Treatment Efficacy, Quality, Safety
Would Legalizing Medical Marijuana Help Curb the Opioid Epidemic?
Prescription-Drug Monitoring Cuts Doctor-Shopping for Painkillers

Tips, Resources to Help Rheumatologists Educate Patients on Biologics and Biosimilars
OIG Releases 2017 Work Plan: A Summary
- 1
- 2
- 3
- …
- 10
- Next Page »